Three cases from one kindred who suffer from dominant paroxysmal ataxia are described. This is a rare benign nonprogressive disorder of childhood onset, characterised by bouts of ataxia with abrupt onset lasting minutes or hours. Cases may be identified on the basis of a suggestive history, nystagmus persisting between episodes, and dominant inheritance. Treatment with acetazolamide is often dramatically effective. This family is thought to be the first described in the UK but many more probably exist, mislabelled as epilepsy or migraine. At a further assessment one year ago, she was screened for the possibility of mitochondrial disease because of slight elevation of creatine kinase (150 units, normal < 120), but a muscle biopsy specimen was normal, and the diagnosis of familial paroxysmal ataxia was made. An MRI scan showed distinct atrophy of the superior cerebellar vermis. Institution of acetazolamide 250 mg twice daily in January 1990 resulted in a dramatic reduction of attacks over the first eight months' observation.
At a further assessment one year ago, she was screened for the possibility of mitochondrial disease because of slight elevation of creatine kinase (150 units, normal < 120), but a muscle biopsy specimen was normal, and the diagnosis of familial paroxysmal ataxia was made. An MRI scan showed distinct atrophy of the superior cerebellar vermis. Institution of acetazolamide 250 mg twice daily in January 1990 resulted in a dramatic reduction of attacks over the first eight months' observation.
Case 2 developed attacks at 1 year identical to his mother (case 1). They were initially suspected to be epileptic, and there seemed to be some response to carbamazepine. Some episodes were induced by physical exercise. He showed minor mental retardation with difficulty in articulation in early life. Neurological examination at 6 years showed numerous caf&-au-lait spots and slight clumsiness of the left arm but no evidence of neurofibromatosis. There was mild concomitant strabismus with nystagmus and jerky saccades on horizontal gaze. An EEG showed increased slow wave activity but a CT scan of the brain was normal. A provisional diagnosis of epilepsy was made once more, followed by treatment with sodium valproate without obvious benefit. The attacks continued about once every six weeks. When the diagnosis was made in his mother, acetazolamide treatment was started and completely abolished attacks over the first three months of observation. MRI scan showed striking atrophy of the cerebellum particularly in the superior vermis.
Case 3 is another son of case 1. His episodes began when aged 6 weeks. According to his mother his head would flop and he would shake. When crawling at age 7 months he would inexplicably wobble. Subsequently episodes of imbalance, similar to his mother and older brother, recurred on a daily basis. Examination at 6 years revealed a mild convergent squint with nystagmus on horizontal gaze and jerky saccades. There were two very small cafe-aulait spots. No lack of limb coordination was detectable. An The first line of treatment is acetazolamide,"5 which is effective in at least half of cases. If acetazolamide fails, phenytoin may be helpful but sometimes worsens symptoms.' This is thought to be the first family with the typical, dominant form of disease to be described in UK but many other families must exist undiagnosed-mislabelled as epilepsy or migraine. Accurate diagnosis in one individual will usually reveal similarly affected family members, all of whom could benefit from effective treatment.
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